This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2014 Sep;61(3):685-7.

doi: 10.1016/j.jhep.2014.05.028. Epub 2014 May 22.

TERT promoter mutations: gatekeeper and driver of hepatocellular carcinoma

Roser Pinyol¹, Victoria Tovar¹, Josep M Llovet²

Affiliations

Affiliations

¹ HCC Translational Research Lab., Barcelona Clinic Liver Cancer (BCLC) Group, Liver Unit, Hospital Clínic Barcelona, IDIBAPS, CIBERehd, University of Barcelona, Spain.
² HCC Translational Research Lab., Barcelona Clinic Liver Cancer (BCLC) Group, Liver Unit, Hospital Clínic Barcelona, IDIBAPS, CIBERehd, University of Barcelona, Spain; Mount Sinai Liver Cancer Program, Division of Liver Diseases, Icahn School of Medicine at Mount Sinai School, New York, NY, USA; Institució Catalana de Recerca i Estudis Avançats, Barcelona, Catalonia, Spain. Electronic address: jmllovet@clinic.cat.

PMID: 24859456
DOI: 10.1016/j.jhep.2014.05.028

Comment

TERT promoter mutations: gatekeeper and driver of hepatocellular carcinoma

Roser Pinyol et al. J Hepatol. 2014 Sep.

. 2014 Sep;61(3):685-7.

doi: 10.1016/j.jhep.2014.05.028. Epub 2014 May 22.

Authors

Roser Pinyol¹, Victoria Tovar¹, Josep M Llovet²

Affiliations

¹ HCC Translational Research Lab., Barcelona Clinic Liver Cancer (BCLC) Group, Liver Unit, Hospital Clínic Barcelona, IDIBAPS, CIBERehd, University of Barcelona, Spain.
² HCC Translational Research Lab., Barcelona Clinic Liver Cancer (BCLC) Group, Liver Unit, Hospital Clínic Barcelona, IDIBAPS, CIBERehd, University of Barcelona, Spain; Mount Sinai Liver Cancer Program, Division of Liver Diseases, Icahn School of Medicine at Mount Sinai School, New York, NY, USA; Institució Catalana de Recerca i Estudis Avançats, Barcelona, Catalonia, Spain. Electronic address: jmllovet@clinic.cat.

PMID: 24859456
DOI: 10.1016/j.jhep.2014.05.028

No abstract available

PubMed Disclaimer

Comment on

High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions.
Nault JC, Mallet M, Pilati C, Calderaro J, Bioulac-Sage P, Laurent C, Laurent A, Cherqui D, Balabaud C, Zucman-Rossi J. Nault JC, et al. Nat Commun. 2013;4:2218. doi: 10.1038/ncomms3218. Nat Commun. 2013. PMID: 23887712 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Other Literature Sources
- scite Smart Citations